Buzatto,I.P.C., Ribeiro-Silva,A., Andrade,J.M., Carrara,H.H.A., Silveira,W.A., & Tiezzi,D.G. (2017). Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: Pathologic complete response rate, predictive and prognostic factors.
Chicago Style CitationBuzatto,I.P.C., Ribeiro-Silva,A, Andrade,J.M, Carrara,H.H.A, Silveira,W.A, and Tiezzi,D.G. Neoadjuvant Chemotherapy With Trastuzumab in HER2-positive Breast Cancer: Pathologic Complete Response Rate, Predictive and Prognostic Factors. 2017.
MLA CitationBuzatto,I.P.C., et al. Neoadjuvant Chemotherapy With Trastuzumab in HER2-positive Breast Cancer: Pathologic Complete Response Rate, Predictive and Prognostic Factors. 2017.
Note: citation formatting may not correspond 100% to that defined by the respective standard, to manage citations it is recommended to use the software Zotero
, which allows the automatic upload of Oasisbr references.